JP2018079145A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018079145A5 JP2018079145A5 JP2016224255A JP2016224255A JP2018079145A5 JP 2018079145 A5 JP2018079145 A5 JP 2018079145A5 JP 2016224255 A JP2016224255 A JP 2016224255A JP 2016224255 A JP2016224255 A JP 2016224255A JP 2018079145 A5 JP2018079145 A5 JP 2018079145A5
- Authority
- JP
- Japan
- Prior art keywords
- mass
- collagen
- sol
- buffer
- sodium chloride
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 8
- 102000008186 Collagen Human genes 0.000 claims 7
- 108010035532 Collagen Proteins 0.000 claims 7
- 229920001436 collagen Polymers 0.000 claims 7
- 239000000872 buffer Substances 0.000 claims 4
- 239000011780 sodium chloride Substances 0.000 claims 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 4
- AZKVWQKMDGGDSV-BCMRRPTOSA-N Genipin Chemical compound COC(=O)C1=CO[C@@H](O)[C@@H]2C(CO)=CC[C@H]12 AZKVWQKMDGGDSV-BCMRRPTOSA-N 0.000 claims 2
- 229910019142 PO4 Inorganic materials 0.000 claims 1
- 208000031737 Tissue Adhesions Diseases 0.000 claims 1
- 239000006172 buffering agent Substances 0.000 claims 1
- 230000010102 embolization Effects 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- AZKVWQKMDGGDSV-UHFFFAOYSA-N genipin Natural products COC(=O)C1=COC(O)C2C(CO)=CCC12 AZKVWQKMDGGDSV-UHFFFAOYSA-N 0.000 claims 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 1
- 239000010452 phosphate Substances 0.000 claims 1
- 239000011148 porous material Substances 0.000 claims 1
- 230000002408 ulcerprotective effect Effects 0.000 claims 1
- 230000002792 vascular Effects 0.000 claims 1
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016224255A JP7012950B2 (ja) | 2016-11-17 | 2016-11-17 | 生体組織孔閉鎖用、潰瘍保護用及び血管塞栓療術用ゾル |
| EP17872367.2A EP3542830B1 (en) | 2016-11-17 | 2017-11-16 | Sol for occluding holes in living tissue, protecting ulcers, and treating vascular embolization |
| KR1020197016712A KR102408275B1 (ko) | 2016-11-17 | 2017-11-16 | 생체 조직 구멍 폐쇄용, 궤양 보호용 및 혈관 색전 치료술용 졸 |
| US16/461,527 US11559602B2 (en) | 2016-11-17 | 2017-11-16 | Sol for tissue perforation closure, ulcer protection, and vascular embolization |
| PCT/JP2017/041238 WO2018092836A1 (ja) | 2016-11-17 | 2017-11-16 | 生体組織孔閉鎖用、潰瘍保護用及び血管塞栓療術用ゾル |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016224255A JP7012950B2 (ja) | 2016-11-17 | 2016-11-17 | 生体組織孔閉鎖用、潰瘍保護用及び血管塞栓療術用ゾル |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018079145A JP2018079145A (ja) | 2018-05-24 |
| JP2018079145A5 true JP2018079145A5 (enExample) | 2018-08-16 |
| JP7012950B2 JP7012950B2 (ja) | 2022-01-31 |
Family
ID=62146513
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016224255A Active JP7012950B2 (ja) | 2016-11-17 | 2016-11-17 | 生体組織孔閉鎖用、潰瘍保護用及び血管塞栓療術用ゾル |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US11559602B2 (enExample) |
| EP (1) | EP3542830B1 (enExample) |
| JP (1) | JP7012950B2 (enExample) |
| KR (1) | KR102408275B1 (enExample) |
| WO (1) | WO2018092836A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102477180B1 (ko) * | 2020-06-04 | 2022-12-14 | 서울대학교산학협력단 | 색전 물질 |
| JP7681288B2 (ja) * | 2020-12-09 | 2025-05-22 | 国立研究開発法人物質・材料研究機構 | ２剤硬化型接着剤、２剤硬化型接着剤用の硬化剤、及び、化合物 |
| JP2022126909A (ja) * | 2021-02-19 | 2022-08-31 | 国立研究開発法人物質・材料研究機構 | 穿孔部閉鎖材、及び、穿孔部閉鎖材の製造方法 |
| CN114404644A (zh) * | 2022-01-20 | 2022-04-29 | 深圳兰度生物材料有限公司 | 医用胶及其制备方法 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5019851B2 (enExample) | 1972-02-18 | 1975-07-10 | ||
| WO1987000062A1 (en) | 1985-07-02 | 1987-01-15 | Target Therapeutics | Vaso-occlusive collagen composition and method |
| US4708718A (en) * | 1985-07-02 | 1987-11-24 | Target Therapeutics | Hyperthermic treatment of tumors |
| US5106949A (en) * | 1989-09-15 | 1992-04-21 | Organogenesis, Inc. | Collagen compositions and methods for preparation thereof |
| EP0466383A1 (en) * | 1990-07-09 | 1992-01-15 | BAUSCH & LOMB INCORPORATED | A collagen medical adhesive and its uses |
| DE69922050T2 (de) | 1999-02-05 | 2005-11-10 | The Regents Of The University Of California, Oakland | Thermoreversibles polymer für intralumenalimplantate |
| JP2006500975A (ja) | 2002-08-02 | 2006-01-12 | ジーピー メディカル | ゲニピンで化学的に処理した薬物担持生体材料 |
| JP4585743B2 (ja) | 2003-02-13 | 2010-11-24 | 独立行政法人物質・材料研究機構 | 生体内分解吸収性粘着性医用材料 |
| EP4023240A1 (en) | 2004-07-06 | 2022-07-06 | 3D Matrix, Inc. | Purified amphiphilic peptide compositions and uses thereof |
| US7749529B2 (en) * | 2005-02-08 | 2010-07-06 | Ash Access Technology, Inc. | Catheter lock solution comprising citrate and a paraben |
| US9327010B2 (en) | 2005-04-25 | 2016-05-03 | Massachusetts Institute Of Technology | Compositions and methods for promoting hemostasis and other physiological activities |
| AU2007208332B2 (en) | 2006-01-25 | 2014-02-06 | University Of Virginia Patent Foundation | Methods for regulating gelation of polysaccharide solutions and uses thereof |
| JP2007325824A (ja) | 2006-06-09 | 2007-12-20 | National Institute For Materials Science | 局所投与型化学療法用材料 |
| JP5019851B2 (ja) | 2006-11-09 | 2012-09-05 | 学校法人 関西大学 | 温度応答性ゾル−ゲル転移を示す生分解性ポリマー及びその製造方法 |
| EP2345433B1 (en) * | 2008-10-06 | 2017-03-01 | 3-D Matrix, Ltd. | Tissue plug |
| JP6071468B2 (ja) | 2012-11-22 | 2017-02-01 | 地方独立行政法人東京都立産業技術研究センター | コラーゲン水溶液及びそれから得られるゲル |
| KR20160003651A (ko) | 2013-03-14 | 2016-01-11 | 가부시끼가이샤 쓰리디 매트릭스 | 위장 폐색 예방용 물질 |
| CN104689381A (zh) | 2013-12-10 | 2015-06-10 | 复旦大学 | 一种消化道黏膜下注射的水凝胶组合物及其应用 |
| DE102014013832A1 (de) | 2014-09-15 | 2016-03-17 | Schock Gmbh | Abflussvorrichtung und Becken mit einer solchen Abflussvorrichtung |
| JP6454125B2 (ja) * | 2014-10-14 | 2019-01-16 | 地方独立行政法人東京都立産業技術研究センター | コラーゲンゲルの作製方法 |
| JP6472635B2 (ja) * | 2014-10-14 | 2019-02-20 | 地方独立行政法人東京都立産業技術研究センター | コラーゲン水溶液及びそれを用いたゲルの製造方法 |
| JP6521746B2 (ja) | 2015-05-29 | 2019-05-29 | キヤノン株式会社 | 画像形成装置 |
| KR102126140B1 (ko) * | 2015-08-11 | 2020-06-24 | 아크로 바이오메디컬 컴퍼니 엘티디 | 고순도 콜라겐 입자의 제조 및 이의 용도 |
-
2016
- 2016-11-17 JP JP2016224255A patent/JP7012950B2/ja active Active
-
2017
- 2017-11-16 KR KR1020197016712A patent/KR102408275B1/ko active Active
- 2017-11-16 WO PCT/JP2017/041238 patent/WO2018092836A1/ja not_active Ceased
- 2017-11-16 EP EP17872367.2A patent/EP3542830B1/en active Active
- 2017-11-16 US US16/461,527 patent/US11559602B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018079145A5 (enExample) | ||
| BR112014017161A2 (pt) | dispositivo de oclusão implantável, método de fazer um dispositivo de oclusão implantável, dispositivo para limitar o fluxo de fluido e método para ocluir um lúmen num tecido corporal | |
| WO2014191738A8 (en) | Degradable haemostat composition | |
| BR112017003302A2 (pt) | sal de adição de ácido do composto inibidor de trk | |
| WO2015084698A3 (en) | Administration and monitoring of nitric oxide in ex vivo fluids | |
| WO2014093489A3 (en) | Hydrogel membrane for adhesion prevention | |
| WO2014168719A8 (en) | Use of microparticles and endothelial cells with decellularized organs and tissues | |
| WO2012017166A3 (fr) | Traitement d'une pathologie liee a un effet excessif du tnf par un compose de benzene sulfonamide | |
| RU2009118942A (ru) | Способ стимуляции регенерации тканей | |
| FI3310761T3 (fi) | Verihiutaleiden varastointimenetelmät ja koostumukset niitä varten | |
| WO2019022588A3 (ko) | Mof를 포함하는 항균제 및 이를 포함하는 항균 필터 | |
| FR21C1049I2 (fr) | Composition pharmaceutique comportant des sels de citrate et de bicarbonate, et son utilisation pour le traitement de la cystinurie | |
| BR112015026685A2 (pt) | agente de diminuição de ácido úrico | |
| EP3585313A4 (en) | ENDOPROTHESIS-FREE BIOPOLYMER HEART VALVE REPLACEMENT THAT CAN REGENERATE LIVING TISSUES | |
| WO2016039979A3 (en) | Vaso-occlusive devices with in-situ stiffening | |
| ES2720954T3 (es) | Formulaciones estabilizadas de estatina | |
| RU2015137706A (ru) | Обрабатывающая жидкость для очистки части имплантата | |
| BR112015030087A2 (pt) | composição compreendendo ácido láctico tamponado | |
| JP2016535044A5 (enExample) | ||
| CR20160188A (es) | Soluciones para incrementar la estabilidad y la vida útil de un órgano y solución de conservación de tejido | |
| JP2019501161A5 (enExample) | ||
| HRP20180178T1 (hr) | Pripravci ketorolaka, namijenjeni zacjeljivanju rane na rožnici | |
| RU2017114136A (ru) | Композиции | |
| MX2018000336A (es) | Fluido terapeutico peritoneal. | |
| NZ599151A (en) | Pharmaceutical composition comprising radezolid or salt thereof and uses thereof |